Phospho-PKC alpha (T638) Recombinant Rabbit Monoclonal Antibody [JF0964]
Catalog# ET1702-17
Phospho-PKC alpha (T638) Recombinant Rabbit Monoclonal Antibody [JF0964]
-
WB
-
IF-Cell
-
IF-Tissue
-
IHC-P
-
IP
-
Dot Blot
-
Human
-
Mouse
-
Rat
-
unconjugated
Overview
Product Name
Phospho-PKC alpha (T638) Recombinant Rabbit Monoclonal Antibody [JF0964]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic phospho-peptide corresponding to residues surrounding Thr638 of Human PKC alpha aa 622-667 / 672.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, IP, Dot Blot
Molecular Weight
Predicted band size: 77 kDa
Positive Control
HEK-293 cell lysate, HeLa cell lysate, NIH/3T3 cell lysate, C6 cell lysate, Mouse brain tissue lysate, Rat brain tissue lysate, NIH/3T3 starved overnight then treated with 200nM TPA for 4 hours cell lysate, HeLa, NIH/3T3, C6, human breast cancer tissue, mouse brain tissue, rat brain tissue.
Conjugation
unconjugated
Clone Number
JF0964
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000
-
IF-Cell
-
1:50-1:500
-
IF-Tissue
-
1:50-1:500
-
IHC-P
-
1:50-1:1,000
-
IP
-
Use at an assay dependent concentration.
-
Dot Blot
-
1:5,000
Target
Function
Members of the protein kinase C (PKC) family play a key regulatory role in a variety of cellular functions including cell growth and differentiation, gene expression, hormone secretion and membrane function. PKCs were originally identified as serine/threonine protein kinases whose activity was dependent on calcium and phospholipids. Diacylglycerols (DAG) and tumor-promoting phorbol esters bind to and activate PKC. PKCs can be subdivided into many different isoforms (α, βI, βII, γ, δ, ε, ζ, η, θ, λ/ι, μ and ν). Patterns of expression for each PKC isoform differ among tissues and PKC family members exhibit clear differences in their cofactor dependencies. For instance, the kinase activities of PKC δ and ε are independent of Ca2+. On the other hand, most of the other PKC members possess phorbol ester-binding activities and kinase activities.
Background References
1. Wang XH et al. Cannabinoid CB1 receptor signaling dichotomously modulates inhibitory and excitatory synaptic transmission in rat inner retina. Brain Struct Funct 221:301-16 (2016).
2. Griffon A et al. Integrative analysis of public ChIP-seq experiments reveals a complex multi-cell regulatory landscape. Nucleic Acids Res 43:e27 (2015).
Sequence Similarity
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
Subcellular Location
Cytoplasm, Cell membrane, Mitochondrion membrane, Nucleus.
Synonyms
AAG6 antibody
Aging associated gene 6 antibody
aPKC antibody
KPCA_HUMAN antibody
PKC alpha antibody
PKC-A antibody
PKC-alpha antibody
PKCA antibody
PRKACA antibody
PRKCA antibody
ExpandAAG6 antibody
Aging associated gene 6 antibody
aPKC antibody
KPCA_HUMAN antibody
PKC alpha antibody
PKC-A antibody
PKC-alpha antibody
PKCA antibody
PRKACA antibody
PRKCA antibody
Protein Kinase C alpha antibody
Protein kinase C alpha type antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-PKC alpha (T638) on different lysates with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/5,000 dilution.
Lane 1: HEK-293 cell lysate (20 µg/Lane)
Lane 2: HeLa cell lysate (20 µg/Lane)
Lane 3: NIH/3T3 cell lysate (20 µg/Lane)
Lane 4: C6 cell lysate (20 µg/Lane)
Lane 5: Mouse brain tissue lysate(40 µg/Lane)
Lane 6: Rat brain tissue lysate(40 µg/Lane)
Lane 3: HeLa cell lysate, the membrane treated with λpp for 1 hour (20 µg/Lane)
Predicted band size: 77 kDa
Observed band size: 77 kDa
Exposure time: 10 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1702-17) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-PKC alpha (T638) on different lysates with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/5,000 dilution.
Lane 1: NIH/3T3 cell lysate
Lane 2: NIH/3T3 starved overnight then treated with 200nM TPA for 4 hours cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 77 kDa
Observed band size: 77 kDa
Exposure time: 10 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1702-17) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of HeLa cells treated with or without λpp labeling Phospho-PKC alpha (T638) with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of NIH/3T3 cells treated with or without λpp labeling Phospho-PKC alpha (T638) with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of C6 cells treated with or without λpp labeling Phospho-PKC alpha (T638) with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Cell treatment (CT)
Immunohistochemical analysis of paraffin-embedded human breast cancer tissue untreated / treated with λpp with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-17) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse brain tissue using anti-Phospho-PKC alpha (T638) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-17, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded rat brain tissue using anti-Phospho-PKC alpha (T638) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-17, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Dot blot analysis of Phospho-PKC alpha (T638) on different peptides with Rabbit anti-Phospho-PKC alpha (T638) antibody (ET1702-17) at 1/5,000 dilution. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution for 1 hour at room temperature.
Lane 1: Phospho-PKC alpha (T638) peptide (positive)
Lane 2: Phospho-PKC beta II (T641) peptide (negative)
Lane 3: Phospho-PKC beta I (T642) peptide (negative)
Lane 4: Unmodified PKC alpha peptide (negative)
Proteins loading: 100ng, 25ng, 5ng;
Blocking and dilution buffer: 5% NFDM/TBST;
Exposure time: 3 seconds; ECL: K1801.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
PDCD5 promotes substrate release from the TRiC complex in cilia and flagella
Journal: Molecular Cell
DOI: 10.1016/j.molcel.2025.12.012
IF: 16.6
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Kukoamine A attenuates allergic rhinitis via H1R antagonism: Dual suppression of inflammatory signaling and epithelial barrier disruption
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2026.117792
IF: 5.6
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Piezo knockdown reduces 5‑hydroxytryptamine release from enterochromaffin cells and exacerbates intestinal dyskinesia in mice with functional constipation
Journal: International Journal Of Molecular Medicine
DOI: 10.3892/ijmm.2025.5619
IF: 5.8
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07341-5
IF: 9.6
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner
Journal: Cell Death & Disease
DOI:
IF: 8.1
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Corydalis yanhusuo extract and its pharmacological substances alleviate food allergy by inhibiting mast cells activation via PLC/PKC/STAT3 pathway
Journal: Journal Of Ethnopharmacology
DOI:
IF: 6.1
Application: WB
Reactivity: Human
Publish date: 2024 Sep
-
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
Journal: Cell Discovery
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIγ/Myc axis.
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 3.74
Application: WB
Reactivity: Human
Publish date: 2019 Sep
Products with the same target and pathway
Phospho-PKC alpha (T497) Recombinant Rabbit Monoclonal Antibody [JE44-81]
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PKC alpha Recombinant Rabbit Monoclonal Antibody [SU31-08]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated